Elitek Kit
FDA Recall NDC 0024-5151

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Elitek (NDC 0024-5151). A significant event, classified as Class II, was initiated on Aug 10, 2020 by Sanofi-aventis U.s. Llc. The reported reason for this action was: "Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing."

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

August 2020 Class II Recall: Failed Stability Specifications

Recall Number
Class II Ongoing
Reason for Recall
Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
Initiated
Aug 10, 2020
Reported
Aug 26, 2020
Quantity
7451 vials

Recall Profile & Regulatory Data

Event ID
86219
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Sanofi-Aventis U.S. LLC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the US
Product Description
Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75
Batch or Lot Expiration Information
Lot# : A9306, Exp 2/28/2022
Affected Packages Involved in this Recall
0024-5150-10Product
0024-5154-11Product
0024-5152-11Product
0024-5151-75Product
0024-5155-74Product
0024-5153-74Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.